We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
+39.57%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$1.03B
AUM Growth
+$88.2M
(+9.4%)
Cap. Flow
-$124M
Cap. Flow
% of AUM
-12.03%
Top 10 Holdings %
Top 10 Hldgs %
68.92%
Holding
48
New
–
Increased
4
Reduced
21
Closed
8
Top Buys
| 1 |
Cogent Biosciences
COGT
|
+$9.02M |
| 2 |
IDEAYA Biosciences
IDYA
|
+$7.49M |
| 3 |
Immunome
IMNM
|
+$1.5M |
| 4 |
Neurogene
NGNE
|
+$449K |
Top Sells
| 1 |
Kymera Therapeutics
KYMR
|
+$35.1M |
| 2 |
Replimune Group
REPL
|
+$26.4M |
| 3 |
HNGE
Hinge Health
HNGE
|
+$15.5M |
| 4 |
Biohaven
BHVN
|
+$10.3M |
| 5 |
Boston Scientific
BSX
|
+$9.16M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Atara Biotherapeutics
ATRA
$77M
| $6.33M | 0.62% |
441,701
| – | – |
|
|
FOLD
27
DELISTED
Amicus Therapeutics
FOLD
| $6.12M | 0.6% |
777,178
-411,820
| -35% | -$2.93M |
|
28
ALX Oncology
ALXO
$273M
| $6.1M | 0.59% |
3,332,983
-58,472
| -2% | -$50.6K |
|
29
Establishment Labs
ESTA
$2.67B
| $5.3M | 0.52% |
129,364
-7,131
| -5% | -$291K |
|
|
CBLL
30
CeriBell Inc
CBLL
$736M
| $5M | 0.49% |
435,239
| – | – |
|
31
Xeris Biopharma Holdings
XERS
$1.5B
| $3.67M | 0.36% |
451,099
| – | – |
|
|
VTYX
32
DELISTED
Ventyx Biosciences
VTYX
| $3.34M | 0.32% |
1,073,386
-41,143
| -4% | -$109K |
|
|
LVTX
33
DELISTED
LAVA Therapeutics
LVTX
| $3.24M | 0.31% |
2,074,372
| – | – |
|
|
RPTX
34
DELISTED
Repare Therapeutics
RPTX
| $2.79M | 0.27% |
1,586,174
| – | – |
|
35
Invivyd
IVVD
$241M
| $2.51M | 0.24% |
2,285,320
| – | – |
|
36
Pliant Therapeutics
PLRX
$69.4M
| $2.36M | 0.23% |
1,591,695
-40,882
| -3% | -$62.4K |
|
|
37
Replimune Group
REPL
$813M
| $2.25M | 0.22% |
535,818
-4,128,973
| -89% | -$26.4M |
|
38
Prime Medicine
PRME
$630M
| $483K | 0.05% |
87,118
-1,987,232
| -96% | -$8.07M |
|
|
KLRS
39
Kalaris Therapeutics
KLRS
$115M
| $479K | 0.05% |
82,955
| – | – |
|
|
BOLD
40
Boundless Bio
BOLD
$55.5M
| $302K | 0.03% |
245,458
-343,576
| -58% | -$397K |
|
|
41
Biohaven
BHVN
$2.24B
| – | – |
-729,515
| Closed | -$10.3M |
|
|
42
Boston Scientific
BSX
$64B
| – | – |
-85,301
| Closed | -$9.16M |
|
43
4D Molecular Therapeutics
FDMT
$611M
| – | – |
-112,168
| Closed | -$416K |
|
|
IGMS
44
DELISTED
IGM Biosciences
IGMS
| – | – |
-2,952,131
| Closed | -$3.31M |
|
|
45
Kymera Therapeutics
KYMR
$9.39B
| – | – |
-803,289
| Closed | -$35.1M |
|
46
Penumbra
PEN
$12.5B
| – | – |
-18,818
| Closed | -$4.83M |
|
|
VERV
47
DELISTED
Verve Therapeutics
VERV
| – | – |
-740,261
| Closed | -$8.31M |
|
|
HNGE
48
Hinge Health
HNGE
$6.64B
| – | – |
-300,000
| Closed | -$15.5M |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO